Skip to content

TriSalus Life Sciences, Inc. TLSI Preferred stock, capital shares reserved for future issuance (in shares)

Preferred stock, capital shares reserved for future issuance (in shares) at other companies

L3Harris Technologies logo
L3Harris TechnologiesLHX
1M
Mondelez International logo
Mondelez InternationalMDLZ
0
eBay logo
eBayEBAY
0
Brand Engagement Network, Inc. logo
Brand Engagement Network, Inc.BNAI
0
BK
BKBK
53.8K0.0%
L3Harris Technologies logo
L3Harris TechnologiesLHX
0

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockCapitalSharesReservedForFutureIssuance.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s preferred stock, capital shares reserved for future issuance (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s preferred stock, capital shares reserved for future issuance (in shares)?
TriSalus Life Sciences, Inc. (TLSI) reported preferred stock, capital shares reserved for future issuance (in shares) of 10M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s preferred stock, capital shares reserved for future issuance (in shares) changed year-over-year?
TriSalus Life Sciences, Inc.'s preferred stock, capital shares reserved for future issuance (in shares) increased by 56.7% year-over-year, from 6.4M to 10M.